- Accession Number
An antibiotic complex produced by Streptomyces kitasatoensis. The complex consists of a mixture of at least eight biologically active components, A1 and A3 to A9. Leucomycins have both antibacterial and antimycoplasmal activities.
Drug Drug Description Spiramycin A macrolide antimicrobial agent used in the treatment of various bacterial infections. Kitasamycin Kitasamycin is a macrolide antibiotic derived from Streptomyces kitasatoensis.
- Drugs & Drug Targets
Drug Target Type Spiramycin 50S ribosomal protein L3 target Kitasamycin Cytochrome P450 3A4 enzyme